Intensity Therapeutics to present at the 2025 San Antonio Breast Cancer Symposium, focused on cancer therapies.

Unusual Whales
2025.12.04 12:48
On December 4, 2025, in Shelton, Connecticut, Intensity Therapeutics, Inc. (Nasdaq: INTS) announced its focus on developing unique cancer treatments through non-covalent, drug-conjugation technology. This late-stage clinical biotechnology company is dedicated to pioneering proprietary therapies.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer